Pandemic Influenza (H1N1) and Mycobacterium tuberculosis Co-infection by 源�以�紐� et al.
Pandemic Influenza (H1N1) and 
Mycobacterium tuberculosis Co-infection
Yehyun Park, M.D., Bum Sik Chin, M.D., Ph.D., Sang Hoon Han, M.D., Ph.D., Yujung Yun, M.D., 
Young Ju Kim, M.D., Jun Yong Choi, M.D., Ph.D., Chang Oh Kim, M.D., Ph.D., Young Goo Song, 
M.D., Ph.D. and June Myung Kim, M.D., Ph.D.
Division of Infectious Diseases, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
We hereby observe four co-infection cases of pandemic influenza H1N1 and Mycobacterium tuberculosis with various 
clinical presentations. It may be prudent to consider M. tuberculosis co-infections when patients with pandemic 
influenza reveal unusual clinical features that do not improve despite appropriate treatments against the influenza, 
especially in Korea, in the endemic areas of M. tuberculosis.
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of MTB has been suggested with pH1N1 influenza infection, 
and tuberculosis was suggested as a possible risk factor as-
sociated with fatal pH1N1 influenza infection8. However, there 
have been few reports about co-infection of pH1N1 and MTB, 
and thus we describe four patients who were infected with 
pH1N1 as well as being confirmed with active MTB infections. 
Case Reports
1. Case 1
A previously healthy 20-year-old woman was admitted on 
December, 2009 because of abdominal pain, fever and 10 kg 
of weight loss during the previous two months. The physical 
examination upon admission revealed a high body tempera-
ture (39.3oC). Laboratory findings were as follows: white blood 
cells (WBC), 4,110/mm3; neutrophils, 76.4%; lymphocytes, 
480/mm3 (11.7%); hemoglobin, 10.2 g/dL; C-reactive protein 
(CRP), 34.9 mg/L; and erythrocyte sedimentation rate, 62 
mm/hr, and a stool occult blood test was positive. A chest 
X-ray showed granular opacity in the bilateral apical area. 
Repetitive sputum acid fast bacilli (AFB) fluorescent smear 
studies were negative. A computed tomographic (CT) scan of 
the abdomen and pelvis revealed diffuse swelling of the liver, 
gallbladder, distal small bowel and ascending colon. Consider-
ing the influenza pandemic period and opacities in the chest 
X-ray, a reverse transcriptase polymerase chain reaction (RT-
PCR) for pH1N1 via nasopharyngeal swab specimen was per-
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Introduction
Pandemic H1N1 2009 influenza (pH1N1) first appeared 
in March 2009 in Mexico. It rapidly spread worldwide, and a 
pandemic was declared by the World Health Organization in 
June 20091. Both Mycobacterium tuberculosis (MTB) and in-
fluenza have been known to impair immune responses such 
as host T-cell immunologic reactions2,3. Therefore, influenza 
may promote the emergence of active tuberculosis in persons 
with latent tuberculosis infections4, and persons with tubercu-
losis may be vulnerable to influenza infections2,5. In addition, 
increased mortality by MTB has been observed during influ-
enza pandemics6,7.
As with other pandemic influenza strains, an additive effect 
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formed, and pH1N1 infection was confirmed on hospital day 
(HOD) 2. The conventional dose of oral oseltamivir (75 mg 
b.i.d.) was prescribed to the patient. On the same day, the pa-
tient complained of hematochezia, and then sigmoidoscopic 
evaluation revealed several polypous and aphthous lesions 
on the cecum and rectum with erythema, edema, granularity 
and telangiectasia, while pathologic evaluation of the biopsy 
specimen revealed acute colitis. Fever and respiratory symp-
tom improved after three days of treatment with oseltamivir, 
but hematochezia had been continued, and after 5 afebrile 
days, fever started to spike again with higher degree up to 
39.7oC. An interferon-gamma releasing assay (QuantiFERON-
TB Gold; Cellestis Ltd., Carnegie, Australia) was positive, and 
the pathology result of colonoscopy done for further evalu-
ation of hematochezia revealed a chronic granulomatous 
inflammation consistent with intestinal tuberculosis, and a 
Ziehl-Neelsen stain revealed acid-fast bacilli. On the next day 
of pathology report, a MTB complex-specific PCR of sputum 
revealed positive results, and the administration of isoniazid, 
rifampin, ethambutol and pyrazinamide was initiated (HOD 
16). Symptoms of fever, abdominal pain and hematochezia 
gradually improved within 5 days of treatment with anti-tu-
berculosis mediation, and the growth of MTB was confirmed 
in the sputum specimens after three weeks of collection.
2. Case 2
A previously healthy 47-year-old man was referred to the 
emergency department (ED) on December, 2009 for dyspnea 
and documentation of pneumonic consolidation in chest 
X-rays from another primary care clinic. He complained of 
two weeks of cough, sputum, and rhinorrhea. Dyspnea upon 
exertion had developed since the day before he visited the ED. 
Laboratory findings were as follows: WBC, 8,260/mm3; neutro-
phils, 80.2%; lymphocytes, 1,050/mm3 (11.7%); and CRP, 79.6 
mg/L. His chest X-ray image revealed heterogenous ground 
glass opacities in bilateral lung fields. For further evaluation of 
the pulmonary lesions, a chest CT was performed, and multi-
segmental involvement of centrilobular nodules with a tree-in-
bud appearance and multiple small cavitary lesions were ob-
served, suggesting active pulmonary tuberculosis. In addition, 
RT-PCR for pH1N1 via nasopharyngeal swab was positive, 
and a serum glucose test registered 404 mg/dL. Admission 
was recommended for proper management of pH1N1 and 
active pulmonary tuberculosis as well as previously unknown 
diabetes mellitus. However, the patient refused admission and 
was discharged with medications such as oseltamivir, isonia-
zid, rifampin, ethambutol, and pyrazinamide. An AFB smear 
reported to be 4+ next day, and improvement of symptoms 
and pulmonary consolidation in chest X-ray were observed 
upon out-patient department follow-up visit after 5 days. Later, 
growth of MTB was confirmed in respiratory specimens. It 
took about 6 months for the lung lesions of heterogenous 
ground glass opacities and consolidations to nearly resolve.
3. Case 3
A 45-year-old man visited the ED on December, 2009 
because of fever and cough for one day and one incident of 
hemoptysis estimated at about 400 mL. He had a history of 
pulmonary tuberculosis diagnosed in 2007 and reported a 
complete recovery after treatment. A physical examination 
upon admission revealed a high body temperature (38.1oC) 
and increased pulse rate (105/min), while his breath sounds 
Figure 1. Chest X-ray and chest computed 
tomography (CT) in case no. 3. Chest X-
ray revealed multiple small nodules and 
patchy consolidations predominantly in 
the left lung field, and the chest CT re-
vealed a cavitary nodule (thin arrow) and 
tree-in-bud appearance in the left up-
per lung and left lingular segment, with 
ground glass opacities (thick arrow) due 
to aspirated blood in the left lower lung, 
that suggests tuberculosis reactivation.
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were clear. Oxygen saturation was 97% under an oxygen sup-
ply of 2 L/min via nasal cannula. Laboratory findings were as 
follows: WBC, 7,110/mm3; neutrophils, 80.8%; lymphocytes, 
650/mm3 (9.1%); and CRP, 6.69 mg/L. A chest X-ray showed 
multiple small nodules and patchy consolidation predomi-
nantly in the left lung field, and chest CT revealed a cavitary 
nodule and tree-in-bud appearance on the left upper lung 
and left lingular segment, with ground glass opacities due to 
aspirated blood on the left lower lung suggesting tuberculosis 
reactivation (Figure 1). However, pH1N1 RT-PCR was posi-
tive for a nasopharyngeal swab specimen, and a conventional 
dose of oral oseltamivir was prescribed. Fever spiking was 
improved after starting oseltamivir, but it remained to lower 
degree for 4 days. Repetitive sputum AFB smears were nega-
tive, while MTB complex-specific PCR was positive. Due to 
suspected active pulmonary tuberculosis, isoniazid, rifampin, 
ethambutol and pyrazinamide were prescribed on HOD 4. 
Fever subsided from the next day of starting anti-tuberculosis 
medication, and respiratory symptoms gradually improved, 
so the patient was discharged on HOD 6. Three weeks after 
collection, a sputum culture revealed growth of MTB.
4. Case 4 
An 88-year-old woman was transferred to the ED on Janu-
ary, 2010 for suspected panperitonitis. She had been diag-
nosed with pneumonia during a prior hospital admission and 
reported that related symptoms improved after 14 days of 
intravenous ceftriaxone and metronidazole administration. 
Upon arrival, the patient complained abdominal pain, mild 
dyspnea, and sputum. The physical examination revealed no 
significant findings except for diffuse tenderness in her whole 
abdomen. Laboratory findings were as follows: WBC, 12,810/
mm3; neutrophils, 89.2%; lymphocytes, 760/mm3 (6.0%); and 
CRP, 182 mg/L. Chest X-ray revealed a mass-like lesion in the 
left upper lung field, and subsequent chest CT revealed left 
bronchial wall narrowing and obstruction with distal consoli-
dation. However, pH1N1 RT-PCR revealed a positive result 
in a nasopharyngeal specimen, and a conventional dose 
of oseltamivir was administered as along with piperacillin/
tazobactam. The patient was thought to also have pseudo-
membranous colitis according to clinical presentation and 
abdomen CT finding, and abdominal pain was improved after 
administration of oral vancomycin.
Despite administration of both anti-bacterial and anti-viral 
agents, pulmonary consolidation did not improve while dys-
pnea and sputum had been improving. After repetitive nega-
tive results of sputum AFB smear studies, growth of MTB was 
identified from the initial respiratory specimens on HOD 15. 
After administration of isoniazid, rifampin, ethambutol, and 
pyrazinamide, pulmonary infiltration observed via chest X-ray 
improved, and the patient was discharged without significant 
sequelae.
Discussion
Interaction between influenza A virus and pulmonary tu-
berculosis has been suggested, and underlying tuberculosis 
infection is considered one of the identifiable risk factors for 
severe influenza infection2,5. This is not only because of the im-
munosuppression in tuberculosis, but also because significant 
percentages of patients treated for tuberculosis are left with 
sequelae of the disease including bronchiectasis, which may 
predispose them to life-threatening influenza A infections6.
There have been a few reports of fatal co-infection cases of 
pandemic influenza and active tuberculosis in South Africa6,8. 
However, South Africa is one of the countries with the high-
est burden of tuberculosis (993 cases per 100,000 popula-
tion)9, and the clinical presentations of tuberculosis are not 
identifiable in these reports. Our data is one of the rare cases 
of co-infection of pandemic influenza and active pulmonary 
tuberculosis in an intermediate tuberculosis-burden country 
(100 cases per 100,000 population)9. We described four cases 
of MTB and pH1N1 co-infection and the variations in their 
clinical presentations. The diagnosis of tuberculosis was de-
layed in case no. 1 because the chief complaints were gastro-
intestinal symptoms and repeated sputum AFB smear studies 
were negative, although the patient proved to have been an 
active case of pulmonary tuberculosis. In addition, it was not 
until the confirmation of tuberculosis through colonoscopic 
biopsy pathology that the positive result of sputum MTB PCR 
was available. In fact, the symptoms of abdominal pain and 
weight loss for 2 months, and chest X-ray finding of granular 
opacity in both apical lung fields instead of lower lung fields 
do not seem typical for H1N1 infection but instead more 
close to tuberculosis, when retrospectively seen. But positivity 
for pH1N1 and initial improvement of fever and respiratory 
symptom after starting oseltamivir might preclude us from 
early suspicion of active tuberculosis. In cases nos. 2 and 3, the 
patients was suspected to have an active pulmonary tubercu-
losis infection, considering past history of pulmonary tuber-
culosis and typical clinical features of hemoptysis in case no. 
3 and cavitary nodules in chest CT study in cases nos. 2 and 3. 
However, in case no. 3, repeated AFB smear studies were neg-
ative despite the classical features. Fortunately, MTB PCR was 
positive in an initial study, and treatment for tuberculosis was 
initiated relatively early in this case. In contrast, the diagnosis 
of tuberculosis was delayed in case no. 4. She was considered 
as a bacterial pneumonia case combined with pH1N1 infec-
tion. Repeated sputum AFB studies were negative, and MTB 
PCR was not performed, unfortunately. But considering that 
obstructive pneumonia is rare in H1N1 infection, tuberculosis 
could have been suspected.
Noh et al.10 previously reported 7 cases of concurrent MTB 
and influenza infection in South Korea. They were mostly 
previous healthy, and clinical outcomes were good for all 
patients. Among 4 patients with available initial lymphocyte 
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count, 2 patients were lymphopenic. In our case reports, three 
among the four patients had prior medical co-morbidities 
such as prior pulmonary tuberculosis, bacterial pneumonia, 
and diabetes mellitus, and the clinical presentations of the co-
infection cases of MTB and the pH1N1 influenza were diverse. 
But these patients have some characteristics in common. 
The clinical presentation and image findings of all patients 
were not typical for H1N1 infection, but rather closer to MTB 
infection. But the diagnosis of pH1N1 was made in advance, 
and this may preclude or mask the diagnosis of tuberculosis 
in these patients. Considering these, it seems more likely that 
the patients who had tuberculosis went through a transient or 
incidental infection of pH1N1 which might have aggravated 
patients’ symptoms. Whether these patients were more sus-
ceptible to pH1N1 because of having tuberculosis infection is 
not clear. One study reported that pulmonary MTB was a risk 
factor for pH1N1 infection5. However, the reports about the 
co-infection of MTB and influenza have been mostly descrip-
tive and could not show the causal relationship. Also, it is not 
clear whether influenza accelerate emergence of MTB. But an-
imal models with mouse suggest the possibility of influenza-
associated MTB11,12, and temporary suppression of T-cell im-
munity by pH1N1 virus was reported13, which might alter the 
course of MTB infection. In our cases, all 4 patients showed 
lymphopenia at initial visit which was recovered within 1 
month. To clarify whether the rapid lymphopenia associated 
with pH1N1 infection is related to the host susceptibility to 
MTB, further studies of serial quantification and functional 
assay of lymphocytes at the acute stage of influenza infection 
and its effect are needed.
The co-infection of MTB and pH1N1 could be an inciden-
tal finding, and the possible interaction between MTB and 
pH1N1 is difficult to prove. Therefore, large-scale epidemio-
logical data may be necessary to evaluate and further under-
stand the interaction between MTB and pH1N1 infection. 
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